Bill Wilson, MD: GLP-1 Fights Carb Syndrome, Monoamine Deficiency, and Insulin Resistance Swings
Transcript excerpt from a conversation between Dr. Ron Najafi and Bill Wilson describing CLARP (Carp) syndrome as monoamine neurotransmitter depletion driven by glucose spikes from ultra-processed foods, and stating that GLP-1 agonists can reverse the syndrome. The excerpt explains an alleged mechanism: rapid postprandial glucose rises and subsequent drops trigger excessive neurotransmitter dumping into synapses, overwhelming reuptake and leading to clearance of neurotransmitters via blood and renal excretion.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet